Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000262117

Medchemexpress LLC RORγt inverse agonist 13 | 2170477-75-3 | 98.1% | 513.29 | C23H17Cl2F3N2O4 | 5 MG
SDP

Catalog No. 5000262117
Encompass_Preferred

RORγt inverse agonist 13 (Compound 3i) is a potent, orally active, and selective inverse agonist of the RORγt nuclear receptor with a reported IC50 of 63.8 nM. The compound is supplied for research use and is available as solid and solution formulations with high analytical purity.

  • Potent inverse agonist of RORγt with IC50 of 63.8 nM.
  • Orally active and selective for RORγt.
  • High purity (98.1%) suitable for research applications.
  • Molecular weight 513.29; formula C23H17Cl2F3N2O4.
  • Available as solid (5-500 mg) and as DMSO solutions for convenient dosing.

Catalog No. 50-002-62117 Supplier Medchemexpress LLC Supplier No. HY1313385MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

RORγt inverse agonist 13 (Compound 3i) is a potent, orally active, and selective inverse agonist of the RORγt nuclear receptor with a reported IC50 of 63.8 nM. The compound is supplied for research use and is available as solid and solution formulations with high analytical purity.

  • Potent inverse agonist of RORγt with IC50 of 63.8 nM.
  • Orally active and selective for RORγt.
  • High purity (98.1%) suitable for research applications.
  • Molecular weight 513.29; formula C23H17Cl2F3N2O4.
  • Available as solid (5-500 mg) and as DMSO solutions for convenient dosing.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.